4.5 Article

Myostatin is associated with the presence and development of acute-on-chronic liver failure

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Gastroenterology & Hepatology

Follistatin-controlled activin-HNF4α-coagulation factor axis in liver progenitor cells determines outcome of acute liver failure

Tao Lin et al.

Summary: The study found that the expression of HNF4 alpha in liver progenitor cells (LPCs) is crucial for determining the clinical outcomes of patients with acute liver failure (ALF). Recovered patients with ALF show normal coagulation function, while those requiring liver transplantation demonstrate abnormal activin/follistatin ratio.

HEPATOLOGY (2022)

Article Gastroenterology & Hepatology

Phase Angle From Bioelectrical Impedance for the Assessment of Sarcopenia in Cirrhosis With or Without Ascites

Astrid Ruiz-Margain et al.

Summary: PhA in cirrhotic patients moderately correlates with SMI for the identification of sarcopenia. Its prognostic accuracy is comparable to SMI and is not influenced by ascites.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)

Article Endocrinology & Metabolism

Myostatin deficiency not only prevents muscle wasting but also improves survival in septic mice

Masayuki Kobayashi et al.

Summary: Sepsis-induced muscle wasting may not just be a complication, but myostatin-mediated cachexic changes could play a role in impaired bacterial clearance and mortality in septic mice. Deficiency of myostatin may prevent muscle wasting and improve survival and bacterial clearance in septic mice, indicating its important role in clinical outcomes.

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2021)

Article Geriatrics & Gerontology

From mitochondria to sarcopenia: Role of inflammaging and RAGE-ligand axis implication

Frederic N. Daussin et al.

Summary: Sarcopenia is characterized by muscle mass and function loss, with mitochondrial alterations considered a key contributor. The pro-inflammatory receptor RAGE is involved in inflammaging and may have a connection with mitochondria in controlling sarcopenia.

EXPERIMENTAL GERONTOLOGY (2021)

Review Gastroenterology & Hepatology

Review article: malnutrition/sarcopenia and frailty in patients with cirrhosis

Chalermrat Bunchorntavakul et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)

Article Multidisciplinary Sciences

Compensatory anabolic signaling in the sarcopenia of experimental chronic arthritis

Robert D. Little et al.

SCIENTIFIC REPORTS (2017)

Article Geriatrics & Gerontology

Elevated serum myostatin level is associated with worse survival in patients with liver cirrhosis

Hiroki Nishikawa et al.

JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2017)

Article Endocrinology & Metabolism

Impaired Follistatin Secretion in Cirrhosis

Anders Rasmussen Rinnov et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)

Article Gastroenterology & Hepatology

Low phase angle is associated with the development of hepatic encephalopathy in patients with cirrhosis

Astrid Ruiz-Margain et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2016)

Article Nutrition & Dietetics

Sarcopenia impairs prognosis of patients with liver cirrhosis

Tatsunori Hanai et al.

NUTRITION (2015)

Article Surgery

Frailty Predicts Waitlist Mortality in Liver Transplant Candidates

J. C. Lai et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2014)

Article Multidisciplinary Sciences

Hyperammonemia in cirrhosis induces transcriptional regulation of myostatin by an NF-κB-mediated mechanism

Jia Qiu et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)

Article Developmental Biology

Follistatin complexes Myostatin and antagonises Myostatin-mediated inhibition of myogenesis

H Amthor et al.

DEVELOPMENTAL BIOLOGY (2004)